{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:28:41Z","timestamp":1791322121223,"version":"4.3.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/olq.0000000000000077","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T21:50:08Z","timestamp":1389304208000},"page":"89-93","source":"Crossref","is-referenced-by-count":20,"title":["Prevalence of Genital Warts Among Sexually Transmitted Disease Clinic Patients\u2014Sexually Transmitted Disease Surveillance Network, United States, January 2010 to December 2011"],"prefix":"10.1097","volume":"41","author":[{"given":"Eloisa","family":"Llata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Stenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Guerry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Kerani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"River","family":"Pugsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Pathela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Tabidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillard","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210213","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/oxfordjournals.epirev.a036020","article-title":"Epidemiology of genital human papillomavirus infection.","volume":"10","author":"Koutsky","year":"1988","journal-title":"Epidemiol Rev"},{"key":"R2-3-20210213","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/OLQ.0b013e31816c5cda","article-title":"National burden of genital warts: a first step in defining the problem.","volume":"35","author":"Dempsey","year":"2008","journal-title":"Sex Transm Dis"},{"key":"R3-3-20210213","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/375074","article-title":"The health and economic burden of genital warts in a set of private health plans in the United States.","volume":"36","author":"Insinga","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R5-3-20210213","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2165\/00019053-200523110-00004","article-title":"Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: Analytic framework and review of the literature.","volume":"23","author":"Insinga","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"R6-3-20210213","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1258\/0956462981921143","article-title":"An international survey of patients with genital warts: Perceptions regarding treatment and impact on lifestyle.","volume":"9","author":"Maw","year":"1998","journal-title":"Int J STD AIDS"},{"key":"R7-3-20210213","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/JCM.37.10.3316-3322.1999","article-title":"Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients.","volume":"37","author":"Brown","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"suppl 3","key":"R8-3-20210213","first-page":"S335","article-title":"Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-611 disease.","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"key":"R9-3-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6532(00)00125-6","article-title":"Human papillomavirus and cancer: The epidemiological evidence.","volume":"19","author":"Munoz","year":"2000","journal-title":"J Clin Virol"},{"key":"R10-3-20210213","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"R11-3-20210213","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group.","volume":"87","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"R12-3-20210213","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R13-3-20210213","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in malesAdvisory Committee on Immunization Practices (ACIP), 2011.","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R14-3-20210213","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(10)62342-2","article-title":"Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study.","volume":"377","author":"Giuliano","year":"2011","journal-title":"Lancet"},{"key":"R15-3-20210213","first-page":"c3493","article-title":"Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: Randomised controlled trial. BMJ (Clinical research ed.","volume":"341","author":"Dillner","year":"2010","journal-title":")"},{"key":"R16-3-20210213","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"R17-3-20210213","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","article-title":"Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: Analysis of national sentinel surveillance data.","volume":"11","author":"Donovan","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"R18-3-20210213","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/infdis\/jis405","article-title":"Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.","volume":"206","author":"Leval","year":"2012","journal-title":"J Infect Dis"},{"key":"R19-3-20210213","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2105\/AJPH.2011.300465","article-title":"Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: An analysis of California public family planning administrative claims data, 2007-2010.","volume":"102","author":"Bauer","year":"2012","journal-title":"Am J Public Health"},{"key":"R20-3-20210213","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2105\/AJPH.2012.301182","article-title":"Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: Potential impact of human papillomavirus vaccination.","volume":"103","author":"Flagg","year":"2013","journal-title":"Am J of Public Health"},{"key":"R21-3-20210213","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1071\/SH09023","article-title":"Prevalence of other sexually transmissible infections in patients with newly diagnosed anogenital warts in a sexual health clinic.","volume":"7","author":"Sturgiss","year":"2010","journal-title":"Sex Health"},{"key":"R22-3-20210213","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2307\/2991551","article-title":"Where do people go for treatment of sexually transmitted diseases.","volume":"31","author":"Brackbill","year":"1999","journal-title":"Fam Plann Perspect"},{"key":"R23-3-20210213","first-page":"264","article-title":"Improving clinical operations: Can we and should we save our STD clinics Sex Transm D","volume":"37","author":"Golden","year":"2010","journal-title":"is"},{"key":"R24-3-20210213","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.olq.0000145851.76025.ad","article-title":"Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States.","volume":"31","author":"Koshiol","year":"2004","journal-title":"Sex Transm Dis"},{"key":"R25-3-20210213","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1185\/03007990903136378","article-title":"Assessing incidence and economic burden of genital warts with data from a US commercially insured population.","volume":"25","author":"Hoy","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"R26-3-20210213","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/OLQ.0b013e3181632d61","article-title":"Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999-2004.","volume":"35","author":"Dinh","year":"2008","journal-title":"Sex Transm Dis"},{"key":"R27-3-20210213","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/infdis\/jir341","article-title":"Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003-2006.","volume":"204","author":"Hariri","year":"2011","journal-title":"J Infect Dis"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/OLQ.0000000000000077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:36:55Z","timestamp":1620967015000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007435-201402000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0000000000000077","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}